Daily Briefing


Pfizer Secures $6 Billion Licensing Deal for Chinese Cancer Drug SSGJ-707
Left 35%
Center 53%
12%
34 Articles; 97% Original ReportingCNBC, Benzinga, Bloomberg, and more
34 Articles; 97% Original ReportingCNBC, Benzinga, Bloomberg, and more
Bias Distribution
Left 35%
Center 53%
12%
Left 35%
Center 53%
12%